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The mechanism by which minoxidil, an adenosine-
triphosphate-sensitive potassium channel opener,
induces hypertrichosis remains to be elucidated.
Minoxidil has been reported to stimulate the produc-
tion of vascular endothelial growth factor, a possible
promoter of hair growth, in cultured dermal papilla
cells. The mechanism of production of vascular
endothelial growth factor remains unclear, however.
We hypothesize that adenosine serves as a mediator
of vascular endothelial growth factor production.
Minoxidil-induced increases in levels of intracellular
Ca2+ and vascular endothelial growth factor produc-
tion in cultured dermal papilla cells were found to be
inhibited by 8-sulfophenyl theophylline, a speci®c
antagonist for adenosine receptors, suggesting that
dermal papilla cells possess adenosine receptors and
sulfonylurea receptors, the latter of which is a well-
known target receptor for adenosine-triphosphate-
sensitive potassium channel openers. The expression
of sulfonylurea receptor 2B and of the adenosine A1,
A2A, and A2B receptors was detected in dermal
papilla cells by means of reverse transcription poly-
merase chain reaction analysis. In order to determine
which of the adenosine receptor subtypes contribute
to minoxidil-induced hair growth, the effects of sub-
type-speci®c antagonists for adenosine receptors
were investigated. Signi®cant inhibition in increase
in intracellular calcium level by minoxidil or adeno-
sine was observed as the result of pretreatment with
8-cyclopentyl-1,3-dipropylxanthine, an antagonist for
adenosine A1 receptor, but not by 3,7-dimethyl-1-
propargyl-xanthine, an antagonist for adenosine A2
receptor, whereas vascular endothelial growth factor
production was blocked by both adenosine A1 and
A2 receptor antagonists. These results indicate that
the effect of minoxidil is mediated by adenosine,
which triggers intracellular signal transduction via
both adenosine A1 and A2 receptors, and that the
expression of sulfonylurea receptor 2B in dermal
papilla cells might play a role in the production of
adenosine. Key words: adenosine receptor/ATP-sensitive
potassium channel/hypertrichosis/intracellular calcium/
vascular endothelial growth factor. J Invest Dermatol
117:1594±1600, 2001
M
inoxidil has been used for patients with severe
hypertension who were refractory to other
treatments (Dargie et al, 1977). The opening of
the adenosine triphosphate (ATP) sensitive
potassium channel (KATP channel), followed by
the generation of membrane potential, results in a reduction of
intracellular calcium ([Ca2+]i) levels and in vascular smooth muscle
relaxation, which is generally thought to contribute to this
hypotensive effect (Andersson, 1992). In addition to this effect,
minoxidil (Earhart et al, 1977; Burton and Marshall, 1979),
pinacidil, diazoxide, and other KATP channel openers (Burton
et al, 1975; Goldberg, 1988) have been reported to cause
hypertrichosis in humans, though the precise mechanisms by
which these drugs induce hair growth remains unclear. It is known,
however, that despite their diverse chemical structures they share a
common feature; namely, their actions of KATP channel opening.
Dermal papilla cells (DPC), which reside at the base of hair follicles,
were highly implicated as the source of regulatory stimuli of hair
growth and development. Therefore, KATP channel opening in
DPC has been suggested as an important mechanism in terms of the
ability of DPC to stimulate hair growth (Buhl et al, 1993).
KATP channels comprise a sulfonylurea receptor (SUR), a
member of the ATP-binding cassette transporter, and an inward
recti®er potassium channel (Aguilar-Bryan et al, 1998). SUR is
considered to be a direct receptor for the KATP channel openers,
which could function as a pump for ATP (Awqati, 1995;
Schwanstecher et al, 1998). Thus far, however, no studies have
been conducted to determine whether SUR is expressed in DPC.
Concerning the activity of the KATP channel in cultured DPC,
minoxidil failed to induce an increase in K+ permeability, either in
the KATP channel or in the Ca
2+-activated K+ channels (Nakaya
et al, 1994; Hamaoka et al, 1997), suggesting that minoxidil-
induced hair growth may be due to other mechanisms that are
independent of potassium channel opening.
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Lachgar et al (1998) reported that minoxidil stimulates the
production of growth factors such as vascular endothelial growth
factor (VEGF) in cultured DPC, and that these growth factors
might promote hair growth. The mechanism by which minoxidil
increases the production of VEGF is not known, however.
Among the possible candidates for stimulators of VEGF
production, adenosine seems to cause essential effects on a variety
of cellular functions by triggering intracellular signal transduction
and subsequent VEGF secretion in an autocrine or paracrine
manner (Shryock and Belardinelli, 1997). With regard to possible
sources of adenosine, ATP, which is secreted either through the
ATP-binding cassette transporter or other currently unknown
pathways (Awqati, 1995), is rapidly converted to adenosine by
ecto-ATPase.
The aim of this study was to address whether minoxidil mediated
by adenosine is capable of increasing [Ca2+]i levels and VEGF
production. Our ®ndings show that minoxidil caused an increase in
[Ca2+]i levels and VEGF production in cultured DPC, and that
these increases were inhibited by 8-sulfophenyl theophylline (8-
SPT), a speci®c antagonist for adenosine A1/A2 receptors (A1R,
A2R). This result suggests the presence of both adenosine receptors
and a direct receptor for minoxidil, possibly SUR, in DPC. We
were also able to con®rm the gene expression of adenosine
receptors and SUR in DPC by means of reverse transcription
polymerase chain reaction (RT-PCR) analysis and subsequent
sequence determination of the PCR products.
MATERIALS AND METHODS
Cell culture DPC were cultured as described previously (Messenger,
1984). Dermal papillae were enucleated from excised hair follicles with
the intact bulbous portion, and then cultured in Dulbecco's modi®ed
Eagle's medium (DMEM) supplemented with 12% fetal bovine serum at
37°C in a humidi®ed atmosphere containing 5% CO2/air. DPC were
subcultured after they had grown out from the papillae and achieved
subcon¯uence.
[Ca2+]i measurements Fura-2/acetoxymethyl ester (Wako Pharma-
ceuticals, Tokyo, Japan) was used for the measurement of [Ca2+]i
concentration. Cells were cultured on 13 mm cover glasses (Matsuura
Industry, Tokyo, Japan) and washed with modi®ed normal Tyrode's
solution, which contained 140 mM NaCl, 4.5 mM KCl, 1 mM CaCl2,
1 mM MgCl2, 10 mM 3-morpholinopropanesulfonic acid, and 10 mM
glucose (pH 7.2±7.4). Fura-2/acetoxymethyl ester (4 mM) was added and
the mixture was incubated for 30 min at 37°C. The cover glass was then
transferred to the circulated temperature-controlled chamber of the
analysis system, an ARGUS-50 (Hamamatsu Photonics, Hamamatsu,
Japan), and the test solution was perfused. Any emitted ¯uorescence in
DPC on the cover slips was measured using a ¯uorescence spectro-
microscope (excitation, 340/380 nm; emission, 510 nm). The results
were expressed as the ratio of the ¯uorescence recorded at 340 nm and
380 nm. Changes in this ratio were detected when minoxidil [in this
study, minoxidil sulfate was used as the active form of minoxidil, and
was synthesized according to the method described by Newgreen et al
(1990)] or adenosine (Wako) was added to the test solution alone or
together with one of the following: the antagonist for A1R/A2R, 8-SPT
(Sigma-Aldrich Chemie, Steinheim, Germany); a speci®c antagonist for
A1R, 8-cyclopentyl-1,3-dipropylxanthine (CPX) (Sigma); or a speci®c
antagonist for A2R, 3,7-dimethyl-1-propargyl-xanthine (DMPX)
(Sigma).
Secretion of VEGF Secreted VEGF from cultured DPC was
determined using a kit for the sandwich enzyme-linked immunosorbent
assay (ELISA) of human VEGF (Genzyme/TECHNE, Minneapolis,
MN). After reaching subcon¯uence, DPC were cultured in a 35 mm
dish with 1% fetal bovine serum for 24 h. Adenosine or minoxidil was
added to 90% con¯uent cultures of DPC alone or together with
antagonists for adenosine receptors. Culture media were then collected
for measurements. Because adenosine and minoxidil are not stable, these
compounds (10 ml of 10±5 M solution) were added to the culture media
at 6 h intervals. After 24 h, the culture media were collected in order to
measure VEGF.
A monoclonal antibody speci®c for VEGF was precoated onto a
microplate. The collected supernates were pipetted into the wells, where
VEGF in the sample was bound by the immobilized antibody. After
washing away any unbound substances, an enzyme-linked polyclonal
antibody, which is speci®c for VEGF, was added to the wells. Following
a wash to remove any unbound antibody±enzyme reagent, a substrate
solution was added to the wells, and the colors developed were
proportional to the amount of VEGF bound in the initial step. Color
development was stopped and the intensity of the color was measured.
RT-PCR and sequence analysis After reaching subcon¯uence in
DMEM medium, DPC were washed with phosphate-buffered saline
(PBS). Total RNA was extracted from the cells using the acid
guanidinium±phenol±chloroform method (Chomczynski and Sacchi,
1987). To determine expression of SURs and adenosine receptors in
DPC, the reverse transcription of 5 mg of total RNA was performed
using the Superscript Preampli®cation System for First Strand cDNA
Synthesis according to the manufacturer's instructions (Life Technologies,
Rockville, MD). The PCR was carried out according to a previously
described method (Rappolee et al, 1988). In brief, the reaction was
performed in 50 ml of reaction mixture, containing 2 ml of reverse
transcription mixture prepared by the preampli®cation system described
above, 1 ml of each gene-speci®c primer (10 mM), and 0.5 ml of 5 units
per ml ``long and accurate'' (LA) taq DNA polymerase (Takara
Biotechnology, Kyoto, Japan). After an initial denaturation step for
1 min at 94°C, the DNA was ampli®ed for 30 cycles at 94°C for 30 s,
various annealing temperatures for 30 s, and at 72°C for 2 min on a
DNA cycler, followed by electrophoresis. Six pairs of speci®c
oligonucleotide primers for each of the receptors were used, as shown in
Table I, and were synthesized by Gibco BRL (Tokyo, Japan). Speci®c
primers for human GAPDH (5¢-CCACCCATGGCAAATTCC-
ATGGCA-3¢, sense, and 5¢-TCTAGACGGCAGGTCAGGTCCACC-
3¢, antisense) were purchased from Clontech (Tokyo, Japan). The
Table I. Primers used in this study
Primer Sequence Database accession no. Annealing temp. Product size
AR1 sense 5¢-TGCTGAAGGCGTCGAGGTGT-3¢ GenBank X68485 60°C 765 bp
antisense 5¢-GCTTGCGGATTAGGTAGAAGAC-3¢
A2AR sense 5¢-CATCATGGGCTCCTCGGT-3¢ GenBank X68486 60°C 633 bp
antisense 5¢-CTCTCCATCTGCTTCAGC-3¢
A2BR sense 5¢-CAACTGCACAGAACCCTG-3¢ GenBank X68487 55°C 479 bp
antisense 5¢-GGCAGAGAAGATACCTGGAG-3¢
SUR1 sense 5¢-CTCCAACTACCTCAACTGGATGC-3¢ GenBank L78207 55°C 922 bp
antisense 5¢-TATGGGCAGGGTCCGAATGTGG-3¢
SUR2A sense 5¢-CCACAAGAAGGGGAGATCAAGA-3¢ DDBJ AF061317.1
(exon32 of SUR2)
55°C 662 bp
antisense 5¢-CACTCCACTAAAATACCCTCAGAA-3¢ DDBJ AF061323.1
(SUR2A speci®c exon38)
SUR2B sense 5¢-CAAATGCACAGATGACAGACT-3¢ DDBJ AF061620.1
(exon35 of SUR2)
52°C 411 bp
antisense 5¢-TCTGCGCGAACAAAAGAAGC-3¢ DDBJ AF061324
(SUR2B speci®c exon38)
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ampli®ed DNA fragments were subcloned into a pT7Blue cloning vector
(TaKaRa Shuzo, Shiga, Japan) and sequenced by means of a BigDye
terminator cycle sequencing kit in an ABI 310 genetic analyzer (ABI
PRISM 310, PE Applied Biosystems).
Statistical analysis Student's t test was used to determine the
signi®cance of differences in ®ndings before and after the application of
adenosine receptor antagonist. p-values of less than 0.05 were considered
signi®cant.
RESULTS
Changes in [Ca2+]i levels by minoxidil and adenosine Based
on the fact that intracellular calcium is a ubiquitous second
messenger, which regulates a wide range of cellular processes
associated with a variety of fundamental cellular functions (Toescu,
1995), including VEGF gene expression (Mukhopadhyay and
Akbarali, 1996), we ®rst examined the effect of adenosine and
minoxidil on [Ca2+]i levels in cultured DPC. As shown in Fig 1(A),
adenosine (10 mM) initially increased the levels of [Ca2+]i (ratio of
340/380 nm) in cultured DPC, followed by a small sustained
elevation of [Ca2+]i. The relation between the dose of adenosine and
the elevation of the [Ca2+]i peak is shown in Fig 1(B).
Minoxidil (30 mM) caused a gradual increase in [Ca2+]i levels
over time in cultured DPC (Fig 1C), although the rate of elevation
was slow. The dose-dependent increase in [Ca2+]i levels by
minoxidil is shown in Fig 1(D). In the absence of extracellular
Ca2+, neither minoxidil nor adenosine caused an increase [Ca2+]i
levels (data not shown).
In order to determine whether the minoxidil-induced increase in
[Ca2+]i levels is mediated by adenosine, the effect of an A1R/A2R
antagonist, 8-SPT, was examined (Fig 2). In the presence of 1 mM
8-SPT alone, the ¯uorescence ratio of 340/380 nm was not altered,
although it was increased at higher concentrations of 8-SPT.
Therefore, we used 1 mM 8-SPT in this experiment. The increase
in [Ca2+]i levels, which was induced by the presence of 10 mM
adenosine or 30 mM minoxidil, was almost completely blocked by
1 mM 8-SPT (Fig 2A, B, open circles).
Changes in VEGF secretion caused by minoxidil and
adenosine Figure 3 shows the secretion of VEGF from
cultured DPC by minoxidil or adenosine. Minoxidil, at a
concentration of 30 mM, and adenosine, at a concentration of
10 mM, signi®cantly increased the production of VEGF (both p
< 0.05), and these increases were suppressed in the presence of
1 mM 8-SPT (both p < 0.05). 1 mM 8-SPT alone had no effect on
the production of VEGF.
Gene expression of adenosine receptors in DPC The
increases in [Ca2+]i levels were inhibited by the A1R/A2R
antagonist, suggesting the presence of adenosine receptors in DPC.
We therefore examined whether the genes encoding adenosine
receptors were expressed in DPC, and, if so, which subtype is
expressed. RT-PCR reactions were performed using speci®c
primers for the A1R, A2AR, and A2BR, followed by agarose gel
electrophoreses of the products. The expected sizes of the speci®c
PCR products were 765 bp for A1R, 633 bp for A2AR, and
479 bp for A2BR (Fig 4). DPC showed bands corresponding to
the expected size of all three of these subtypes of adenosine
receptors. Sequence analyses of these products were performed after
subcloning them into the pT7Blue cloning vector. All of the
sequences were identical with those found in the DDBJ database
(data not shown).
Effect of subtype-speci®c adenosine receptor antagonist on
minoxidil-induced increase in [Ca2+]i levels and VEGF
production Based on the ®nding that gene expression of all of
A1R, A2AR, and A2BR were detected in DPC, we focused
attention on which of these receptors contributes to the minoxidil-
induced increase in [Ca2+]i levels and VEGF production. The
receptor subtypes involved were characterized using the selective
receptor antagonists CPX and DMPX, selective antagonists for
A1R and A2R, respectively. The increase in [Ca2+]i levels, as
Figure 1. Changes in [Ca2+]i levels caused by
adenosine and minoxidil. The test solution
containing adenosine (10 mM) caused a signi®cant
increase in [Ca2+]i levels in cultured DPC, as
evidenced by the appearance of an initial peak
(A). The test solution containing minoxidil
(30 mM) alone also caused a signi®cant increase in
[Ca2+]i levels (C), at a slower rate than that with
adenosine, followed by a steady increase over
time. Concentration-dependent elevations of
[Ca2+]i are shown in (B) and (D), respectively.
The increase was signi®cant at 100 mM in
adenosine and at 300 mM in minoxidil (n > 7 at
each point). *, +, p < 0.05 and p < 0.01 vs
control, respectively.
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induced by 10 mM adenosine (Fig 5A, B, closed circles) was almost
completely blocked by 5 nM CPX (Fig 5A, open triangles), but not
by 3 mM DMPX (Fig 5B, open squares). Similar results were
obtained when minoxidil was used in place of adenosine (Fig 5C,
open triangles, and Fig 5D, open squares). To exclude the possibility
of direct involvement of the adenosine receptor antagonist in the
changes in [Ca2+]i levels, either 5 nM CPX or 3 mM DMPX alone
was added to the DPC culture. In the presence of either of these,
the ¯uorescence ratio of 340/380 nm was not altered (data not
shown). To summarize, a signi®cant inhibition in the increase in
[Ca2+]i levels caused by adenosine (Fig 5E) or minoxidil (Fig 5F)
was observed in the case of CPX (both p < 0.01), whereas no
change was observed when DMPX was used.
We also tested the effects of CPX and DMPX on minoxidil-
induced secretion of VEGF. In contrast, the increase in VEGF
production induced by 10 mM adenosine or 30 mM minoxidil was
inhibited by both 5 nM CPX (both p < 0.05) and 3 mM DMPX
(both p < 0.05) (Fig 6). Neither 5 nM CPX nor 3 mM DMPX
altered the production of VEGF.
Gene expression of SUR2B in DPC Based on the data
presented above, we assume that the effect of minoxidil is mediated
by adenosine in cultured DPC, which suggests the endogenous
production of adenosine or a precursor thereof in response to
minoxidil. Given that SUR might function as a pump for ATP
(Awqati, 1995), the expression of SUR, a target receptor for KATP
channel openers, was investigated in DPC. RT-PCR was
performed using speci®c primers for SUR1, SUR2A, and
SUR2B, followed by agarose gel electrophoreses of the products.
Among these three subtypes, only the SUR2B product was
detected at the expected size of 411 bp (Fig 7). Subsequent
sequence analysis revealed that the sequence was identical to that
submitted to the DDBJ database (data not shown).
Figure 2. Effects of a speci®c antagonist for adenosine receptors
on the minoxidil-induced increase in [Ca2+]i levels. The effect of
the antagonist for A1R/A2R, 8-SPT, was tested on the adenosine-
induced increase in [Ca2+]i levels (A). In the presence of 8-SPT (open
circles), the increase in [Ca2+]i levels by adenosine (closed circles) was
blocked (n = 8). The effect of 8-SPT was tested on the minoxidil-
induced increase in [Ca2+]i levels (B). In the presence of 8-SPT (open
circles), minoxidil (n = 10) did not cause an increase in [Ca2+]i levels,
compared with the increase caused by the test solution containing
minoxidil alone (closed circles).
Figure 3. Production of VEGF by adenosine or minoxidil in
cultured DPC. The addition of 10 mM adenosine (n = 8) or 30 mM
minoxidil (n = 8) for 24 h increased the production of VEGF. These
increases were signi®cantly suppressed in the presence of 1 mM 8-SPT,
an A1R/A2R antagonist. 1 mM SPT alone did not cause a change in
VEGF production in cultured DPC. *p < 0.05 vs control.
Figure 4. RT-PCR analyses con®rmed the expression of
adenosine receptors in DPC. cDNAs from DPC (lane 2 s) were
ampli®ed with primers speci®c for A1R, A2AR, and A2BR. Lane 1 s
shows the PCR product of human vascular endothelial cells, which were
used as a positive control. GAPDH mRNA was used as a quantitative
RNA control. The sizes expected for the speci®c PCR products are
shown on the right. M, marker.
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DISCUSSION
The elevation of [Ca2+]i and the production of VEGF are known
to stimulate cell proliferation. This study showed that minoxidil
increased both [Ca2+]i levels and VEGF production in cultured
DPC in a manner similar to that of adenosine, and these increases
were inhibited by an adenosine receptor antagonist. Thus, we
hypothesize that the stimulation of DPC by minoxidil activated an
adenosine/adenosine receptor signal transduction pathway (Fig 8).
In support of this hypothesis, the presence of adenosine receptors in
DPC was investigated, revealing the presence of all of the A1R,
A2AR, and A2BR subtypes.
VEGF not only is a potent stimulator of vasodilation,
microvascular hyperpermeability, and angiogenesis, but also serves
as a multifunctional growth factor for a variety of cells. Lachgar et al
(1996) reported that DPC express VEGF, and that VEGF acts on
DPC as an autocrine growth factor. They (Lachgar et al, 1998) also
found that the production of VEGF is promoted by minoxidil in
cultured DPC, and concluded that minoxidil promotes hair growth
via the induced VEGF. The molecular mechanisms governing
VEGF production by minoxidil have not yet been clearly
elucidated, however.
Adenosine stimulates VEGF production through the activation
of cell surface adenosine receptors (Hashimoto et al, 1994; Takagi
et al, 1996). This study has shown that minoxidil, like adenosine,
has a positive effect on promoting [Ca2+]i and VEGF production,
and that these effects are blocked by speci®c adenosine receptor
antagonists, indicating that minoxidil-induced hair growth is
mediated by adenosine. The gene expression of adenosine receptors
in DPC con®rmed the endogenous production of VEGF. The
structure of adenosine receptors governs the various facets of
subtype activity (Olah and Stiles, 2000). A functional subtype
determination experiment in our study demonstrated that the
receptors involved in the effect of increasing [Ca2+]i levels belong
to the A1R subtype, and that, on the other hand, VEGF
production could be activated via both A1R and A2R within the
same DPC. These results indicate that DPC themselves possess
multiple adenosine-dependent signaling pathways.
The opening of KATP channels has been considered to be a
common mechanism for the action of minoxidil and a set of
potassium channel openers (Buhl et al, 1993). Several investigators
have described a bene®cial effect of the KATP channel on
cardioprotective vasorelaxation associated with adenosine receptors
(Kato et al, 2000; Roscoe et al, 2000). There are three possibilities
Figure 5. Effects of subtype-selective
antagonists for adenosine receptors on the
minoxidil-induced increase in [Ca2+]i levels.
The increases caused by either adenosine (n = 8)
or minoxidil (n = 8) were completely inhibited
when 5 nM CPX, a selective antagonist for A1R,
was added to the test solution (open triangles, A
and C), but this was not the case when 3 mM
DMPX, a selective antagonist for A2R, was added
(open squares, B and D). (A) The test solution
contained adenosine in the presence (open triangles)
or absence (closed circles) of CPX; (B) adenosine in
the presence (open squares) or absence (closed circles)
of DMPX; (C) minoxidil in the presence (open
triangles) or absence (closed diamonds) of CPX; (D)
minoxidil in the presence (open squares) or absence
(closed diamonds) of DMPX. Statistical analysis
showed a signi®cant inhibitory effect of CPX on
both the adenosine-induced (E) and minoxidil-
induced (F) increase in [Ca2+]i levels.
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regarding this process: (i) KATP channels could activate adenosine
receptors directly, although no evidence is currently available to
suggest that a binding site for KATP channel openers exists in
adenosine receptors ± thus far, SUR is considered to be a receptor
for minoxidil, and to have a speci®c binding site for the KATP
channel opener; (ii) KATP channels couple to adenosine receptors
via mediators, such as G proteins (Kirsch et al, 1990). (iii) KATP
channel openers act not only to open an inward recti®er potassium
channel but also to promote the secretion of ATP either through
SUR or via an unknown pathway (Awqati, 1995; Kitakaze et al,
1996). ATP is rapidly converted to adenosine by ecto-ATPase. Our
results strongly indicate the possibility that a contribution by SUR
has an effect on the minoxidil-activated adenosine signal transduc-
tion pathway.
Three subtypes of SURs have been recognized to date:
pancreatic type (SUR1), the inhibition of which facilitates insulin
secretion; cardiac type (SUR2A), which provides myocardial
protection; and vascular smooth muscle type (SUR2B), which
plays a role in vasorelaxation (Yokoshiki et al, 1998). Differential
sensitivity to sulfonylureas or dizaoxide has been shown among
these three isoforms (Aguilar-Bryan et al, 1998). This study has
shown that SUR2B, but not SUR1 or SUR2A, is present in DPC,
which is consistent with the report that minoxidil has a speci®c
af®nity for SUR2B (Schwanstecher et al, 1998). The expression of
SUR2B in DPC provides a possible binding site to minoxidil and a
potential mediator for adenosine production.
We postulated that the adenosine/VEGF pathway in cultured
DPC might play an important role in hair growth. Our study was
performed in cultured cells, however, which might be a limitation
of this study. A recent in situ study (Yano et al, 2001) showed that
upregulation of VEGF mRNA was found only in the outer root
sheath keratinocytes, but not in DPC, of the anagen murine hair
follicle. The angiogenic activity of the rat vibrissa hair follicle
associated with the epithelial hair bulb (Stenn et al, 1988) might be
partly due to this upregulation. A study by Lachgar et al (1998) and
this study, however, showed de®nitively increased VEGF expres-
sion in cultured DPC by treatment with minoxidil. In addition,
Kozlowska et al (1998) showed the immunohistochemical expres-
sion of VEGF in DPC. The discrepancy between in vitro and in vivo
results has also been observed in the apoptosis of DPC. It is notable
that DPC undergo apoptosis in culture (Ferraris et al, 1997) but
appear not to during embryogenesis (Wessels and Roessner, 1965)
and throughout the hair cycle in adults (Couchman, 1993;
Nutbrown and Randall, 1995), suggesting that the normal
quiescent state of DPC in vivo may confer protection from
induction of cell death. As natural DPC exist in a complex
epithelial±mesenchymal microenvironment, some characteristics
in vitro may be suppressed in order to keep the physiologic balance.
The inherent abilities of DPC might be released in vivo under the
in¯uence of special endogenous pathologic factors or exogenous
stimulation. Given that adenosine-induced upregulation of VEGF
expression is found in various cell types both in vivo (Martin et al,
1998) and in vitro (Gu et al, 1999), a similar mechanism on cultured
DPC by minoxidil is expected to found in vivo under the in¯uence
of stimulation with topical minoxidil.
Herein, we propose a mechanism for minoxidil-induced VEGF
production in cultured DPC, and conclude that an adenosine-
mediated signal transduction pathway contributes to minoxidil-
induced hair growth. The gene expression of a number of receptors
such as SUR2B, along with that of adenosine receptors in DPC,
emphasizes the important role of DPC in hair growth.
We would like to thank Dr. Yuji Shishido for valuable discussions and suggestions
(Division of Gene Regulatorics, The Institute for Enzyme Research, The
University of Tokushima, Tokushima, Japan).
Figure 6. Effects of subtype-selective antagonists for adenosine
receptors on the minoxidil-induced VEGF production. The
increase in VEGF production caused by either adenosine (n = 5) or
minoxidil (n = 5) was inhibited when 5 nM CPX or 3 mM DMPX was
added to the test solution for 24 h of incubation. VEGF production
induced by 10 mM adenosine or 30 mM minoxidil was inhibited by
5 nM CPX and 3 mM DMPX, respectively. Neither 5 nM CPX nor
3 mM DMPX had any effect on VEGF production in cultured DPC.
*p < 0.05 vs control.
Figure 7. RT-PCR analysis con®rmed the expression of SUR2B
in DPC. cDNAs from DPC (lane 2) were ampli®ed with primers
speci®c for SUR2B. The PCR product of human aortic smooth muscle
cell cDNA (lane 1) was used as a positive control and GAPDH mRNA
was used as a quantitative RNA control. The size expected for the
speci®c PCR product is shown on the right. M, marker.
Figure 8. Proposed signaling pathway mediating minoxidil
action in cultured DPC. The proposed pathway links minoxidil-
induced VEGF upregulation to adenosine, and adenosine receptors
mediate the increase in [Ca2+]i levels and VEGF production in cultured
DPC. SUR is proposed to be a target receptor for minoxidil and a
source of ATP and adenosine production, respectively.
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